Since mutations in the BRCA1/2 genes, involved in DDR, are common in high-grade serous ovarian cancer, and increase mutational burden, thus the correlation between miR-211 expression and mutation burden might be influenced by the BRCA mutation status. This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.